Home/Filings/4/0000905718-19-000096
4//SEC Filing

Miles Michael Glenn 4

Accession 0000905718-19-000096

CIK 0001349929other

Filed

Jan 31, 7:00 PM ET

Accepted

Feb 1, 4:01 PM ET

Size

4.6 KB

Accession

0000905718-19-000096

Insider Transaction Report

Form 4
Period: 2019-01-31
Miles Michael Glenn
Chief Financial Officer
Transactions
  • Purchase

    Common Stock, par value $0.0001 per share

    2019-01-31$0.23/sh+150,000$34,500150,000 total

Documents

1 file

Issuer

CANCER GENETICS, INC

CIK 0001349929

Entity typeother

Related Parties

1
  • filerCIK 0001760938

Filing Metadata

Form type
4
Filed
Jan 31, 7:00 PM ET
Accepted
Feb 1, 4:01 PM ET
Size
4.6 KB